万维提示：
1、投稿方式：在线投稿。
2、期刊网址：
https://journals.lww.com/jcraniofacialsurgery/pages/default.aspx
3、投稿网址：http://www.editorialmanager.com/scs/
4、官网邮箱：mbhabal@verizon.net（主编）
5、期刊刊期：一年出版8期。
2021年7月5日星期一
投稿须知【官网信息】
Instructions for Authors
Announcement:
Effective February 15th, 2021 The Journal of Craniofacial Surgery will implement a submission fee for all standard submissions of all categories of $75.00 USD that is non-refundable to defray the cost of processing of all scholarly scientific submitted articles of all categories. The fee will cover expenses for the scanning, evaluation, and final disposition of your submission by the Journal of Craniofacial Surgery editorial office. The fee will not include editorials and invited submissions by the Editor-in-Chief. Please email Dr. Habal, Editor-in-Chief of Journal of Craniofacial Surgery, with any questions at mbhabal@verizon.net. We hope that will not inconvenience those who are eager to get their work disseminated as our main goal will continue to be education.
Instructions for Authors
SCOPE
The Journal of Craniofacial Surgery is a peer reviewed, multidisciplinary journal directed to an audience of craniofacial surgeons. The journal publishes original articles in the form of clinical and basic research, scientific advances, and selected abstracts from international journals.
Composite Example
Ethical/Legal Considerations: A submitted manuscript must be an original contribution not previously published (except as an abstract or preliminary report), must not be under consideration for publication elsewhere, and if accepted, it must not be published elsewhere in similar form, in any language, without the consent of Lippincott Williams & Wilkins. Each person listed as an author is expected to have participated in the study to a significant extent. Although the editors and referees make every effort to ensure the validity of published manuscripts, the final responsibility rests with the authors, not with the journal, its editors, or the publisher. All manuscripts must be submitted on-line through the journal’s Web site at http://scs.edmgr.com. See submission instructions under “On-line manuscript submission.”
The editorial office will acknowledge receipt of your manuscript and will give you a manuscript number for reference. Address all inquiries regarding manuscripts not yet accepted or published to the journal's editorial office.
Patient anonymity and informed consent: It is the author's responsibility to ensure that a patient's anonymity be carefully protected and to verify that any experimental investigation with human subjects reported in the manuscript was performed with informed consent and following all the guidelines for experimental investigation with human subjects required by the institution(s) with which all the authors are affiliated. Authors MUST submit patient consent forms/photographic release forms AT THE TIME THE MAUSCRIPT IS SUBMITTED. Please note, masking patients' eyes will NOT suffice. The journal will gladly accept consent completed at your office on your letter head. If you do not have this, the journal's form can be downloaded with the link listed above. If you submit your paper without the form, your paper will be returned.
Copyright/Authorship Verification: THIS PROCESS HAS BEEN UPDATED. The corresponding author completes this information during the submission process through a series of questions on the Additional Information screen. All co-authors are emailed an Authorship Verification link upon submission to complete their information. NO MORE PDF FORMS TO COMPLETE.
Conflict of Interest: Authors must state all possible conflicts of interest in the manuscript, including financial, consultant, institutional and other relationships that might lead to bias or a conflict of interest. If there is no conflict of interest, this should also be explicitly stated as none declared. All sources of funding should be acknowledged in the manuscript. All relevant conflicts of interest and sources of funding should be included on the title page of the manuscript with the heading “Conflicts of Interest and Source of Funding:” For example:
Conflicts of Interest and Source of Funding: A has received honoraria from Company Z. B is currently receiving a grant (#12345) from Organization Y, and is on the speaker’s bureau for Organization X – the CME organizers for Company A. For the remaining authors none were declared.
Open access
LWW's hybrid open access option is offered to authors whose articles have been accepted for publication. With this choice, articles are made freely available online immediately upon publication. Authors may take advantage of the open access option at the point of acceptance to ensure that this choice has no influence on the peer review and acceptance process. These articles are subject to the journal's standard peer-review process and will be accepted or rejected based on their own merit.
Authors of accepted peer-reviewed articles have the choice to pay a fee to allow perpetual unrestricted online access to their published article to readers globally, immediately upon publication. The article processing charge for the Journal of Craniofacial Surgery is CCBY-NC-ND: $2,400 and CCBY: $2,850. If the author choses to publish their paper Open Access, they must notify the journal office within 48 hours of receiving their acceptance letter and return the completed License to Publish (LTP) forms. The publication fee is charged when the author notifies the journal office and should be paid within 30 days by credit card by the author, funding agency or institution. Payment must be received in full for the article to be published open access. Any additional standard publication charges, such as for color images, will also apply.
Authors retain copyright
Authors retain their copyright for all articles they opt to publish open access. Authors grant LWW a license to publish the article and identify itself as the original publisher.
Creative Commons license
Articles opting for open access will be freely available to read, download and share from the time of publication. Articles are published under the terms of the Creative Commons License Attribution-NonCommerical No Derivative 3.0 which allows readers to disseminate and reuse the article, as well as share and reuse of the scientific material. It does not permit commercial exploitation or the creation of derivative works without specific permission. To view a copy of this license visit: http://creativecommons.org/licenses/by-nc-nd/3.0.
Compliance with NIH, RCUK, Wellcome Trust and other research funding agency accessibility requirements
A number of research funding agencies now require or request authors to submit the post-print (the article after peer review and acceptance but not the final published article) to a repository that is accessible online by all without charge. As a service to our authors, LWW identifies to the National Library of Medicine (NLM) articles that require deposit and transmits the post-print of an article based on research funded in whole or in part by the National Institutes of Health, Howard Hughes Medical Institute, or other funding agencies to PubMed Central. The revised Copyright Transfer Agreement provides the mechanism. LWW ensures that authors can fully comply with the public access requirements of major funding bodies worldwide. Additionally, all authors who choose the open access option will have their final published article deposited into PubMed Central.
RCUK and Wellcome funded authors can choose to publish their paper as open access with the payment of an article process charge (gold route), or opt for their accepted manuscript to be deposited (green route) into PMC with an embargo.
With both the gold and green open access options, the author will continue to sign the Copyright Transfer Agreement (CTA) as it provides the mechanism for LWW to ensure that the author is fully compliant with the requirements. After signature of the CTA, the author will then sign a License to Publish where they will then own the copyright. Those authors who wish to publish their article via the gold route will be able to publish under the terms of the Attribution 3.0 (CCBY) License. To view of a copy of this license visit: http://creativecommons.org/licenses/by/2.0/. Those authors who wish to publish their article via the green route will be able to publish under the rights of the Attribution Non-commercial 3.0 (CCBY NC) license (http://creativecommons.org/licenses/by-nc/2.0/).
It is the responsibility of the author to inform the Editorial Office and/or LWW that they have RCUK funding. LWW will not be held responsible for retroactive deposits to PMC if the author has not completed the proper forms.
FAQ for open access
http://links.lww.com/LWW-ES/A48
Compliance with NIH and Other Research Funding Agency Accessibility Requirements
A number of research funding agencies now require or request authors to submit the post-print (the article after peer review and acceptance but not the final published article) to a repository that is accessible online by all without charge. As a service to our authors, LWW will identify to the National Library of Medicine (NLM) articles that require deposit and will transmit the post-print of an article based on research funded in whole or in part by the National Institutes of Health, Wellcome Trust, Howard Hughes Medical Institute, or other funding agencies to PubMed Central. The revised Copyright Transfer Agreement provides the mechanism.
Permissions: Authors must submit written permission from the copyright owner (usually the publisher) to use direct quotations, tables, or illustrations that have appeared in copyrighted form elsewhere, along with complete details about the source.
Manuscript Submission
On-line manuscript submission: All manuscripts must be submitted on-line through the new Web site: http://scs.edmgr.com. First-time users: Please click the Register button from the menu and enter the requested information. On successful registration, you will be sent an e-mail indicating your user name and password. Print a copy of this information for future reference. Note: If you have received an e-mail from us with an assigned user ID and password, or if you are a repeat user, do not register again. Just log in. Once you have an assigned ID and password, you do not have to re-register, even if your role changes (that is, author, reviewer, or editor). Authors: Please click the log-in button from the menu at the top of the page and log into the system as an Author. Submit your manuscript according to the author instructions. You will be able to track the progress of your manuscript through the system. If you experience any problems, please contact the editorial office.
Language and Editing Services
It is important that papers are submitted using proper grammar and syntax. Non-native English-speaking authors may consider the aid of editing services.
Wolters Kluwer, in partnership with Editage, offers a unique range of editorial services to help you prepare a submission-ready manuscript:
Premium Editing: Intensive language and structural editing of academic papers to increase chances of journal acceptance.
Advanced Editing: A complete language, grammar, and terminology check to give you a publication-ready manuscript.
Translation with Editing: Write your paper in your native language and Wolters Kluwer Author Services will translate it into English, as well as edit it to ensure that it meets international publication standards.
Plagiarism Check: Helps ensure that your manuscript contains no instances of unintentional plagiarism.
Artwork Preparation: Save precious time and effort by ensuring that your artwork is viewed favorably by the journal without you having to incur the additional cost of purchasing special graphics software.
For more information (including pricing), please visit Wolters Kluwer Author Services
Preparation of Manuscript
Manuscripts that do not adhere to the following instructions will be returned to the corresponding author for technical revision before undergoing peer review.
Title page: Include on the title page (a) complete manuscript title; (b) authors' full names, highest academic degrees, and affiliations; (c) name and address for correspondence, including fax number, telephone number, and e-mail address; (d) address for reprints if different from that of corresponding author; and (e) sources of support that require acknowledgment.
The title page must also include disclosure of funding received for this work from any of the following organizations: National Institutes of Health (NIH); Wellcome Trust; Howard Hughes Medical Institute (HHMI); and other(s).
Unstructured abstract and key words: Limit the abstract to 250 words. It must be factual and comprehensive. Limit the use of abbreviations and acronyms, and avoid general statements (eg, "the significance of the results is discussed"). List three to five key words or phrases.
Text: Organize the manuscript into four main headings: Introduction, Materials and Methods, Results, and Discussion. Define abbreviations at first mention in text and in each table and figure. If a brand name is cited, supply the manufacturer's name and address (city and state/country). Acknowledge all forms of support, including pharmaceutical and industry support, in an Acknowledgments paragraph. DO NOT EMBED IMAGES OR TABLES. Your paper will be returned to you if you embed your files.
Abbreviations: For a list of standard abbreviations, consult the Council of Biology Editors Style Guide (available from the Council of Science Editors, 9650 Rockville Pike, Bethesda, MD 20814) or other standard sources. Write out the full term for each abbreviation at its first use unless it is a standard unit of measure.
References: The authors are responsible for the accuracy of the references. Numerically cite the references in the text in the order of appearance, NOT by name and date. Key the references (double-spaced) at the end of the manuscript in the order they appeared in the manuscript, not alphabetically. Cite unpublished data, such as papers submitted but not yet accepted for publication or personal communications, in parentheses in the text. If there are more than three authors, name only the first three authors and then use et al. Refer to the List of Journals Indexed in Index Medicus for abbreviations of journal names, or access the list at http://www.nlm.nih.gov/tsd/serials/lji.html. Sample references are given below:
Journal article
1. Farkas LG, Tompson B, Phillips JH, et al. Comparison of anthropometric and cephalometric measurements of the adult face. J Craniofacial Surg 1999;10:18-25
Book chapter
2. Todd VR. Visual information analysis: frame of reference for visual perception. In: Kramer P, Hinojosa J. eds. Frames of Reference for Pediatric Occupational Therapy. Philadelphia: Lippincott Williams & Wilkins, 1999:205-256
Entire book
3. Kellman RM, Marentette LJ. Atlas of Craniomaxillofacial Fixation. Philadelphia: Lippincott Williams & Wilkins 1999
Software
4. Epi Info [computer program]. Version 6. Atlanta: Centers for Disease Control and Prevention; 1994
Online journals
5. Friedman SA. Preeclampsia: a review of the role of prostaglandins. Obstet Gynecol [serial online]. January 1988;71:22-37. Available from: BRS Information Technologies, McLean, VA. Accessed December 15, 1990
Database
6. CANCERNET-PDQ [database online]. Bethesda, MD: National Cancer Institute; 1996. Updated March 29, 1996
World Wide Web
7. Gostin LO. Drug use and HIV/AIDS [JAMA HIV/AIDS web site]. June 1, 1996. Available at: http://www.ama-assn.org/special/hiv/ethics. Accessed June 26, 1997
Figures:
A) Creating Digital Artwork
Learn about the publication requirements for Digital Artwork: http://links.lww.com/ES/A42
Create, Scan and Save your artwork and compare your final figure to the Digital Artwork Guideline Checklist (below).
Upload each figure to Editorial Manager in conjunction with your manuscript text and tables.
B) Digital Artwork Guideline Checklist
Here are the basics to have in place before submitting your digital artwork:
Artwork should be saved as TIFF, EPS, or MS Office (DOC, PPT, XLS) files. High resolution PDF files are also acceptable.
Crop out any white or black space surrounding the image.
Diagrams, drawings, graphs, and other line art must be vector or saved at a resolution of at least 1200 dpi. If created in an MS Office program, send the native (DOC, PPT, XLS) file.
Photographs, radiographs and other halftone images must be saved at a resolution of at least 300 dpi.
Photographs and radiographs with text must be saved as postscript or at a resolution of at least 600 dpi.
Each figure must be saved and submitted as a separate file. Figures should not be embedded in the manuscript text file.
Figure Composites
Figure Composites are often requested in an effort to save publication space. When creating a composite, your figures should be combined into one file. Your figure names must also be changed to reflect one figure for example if combining figures 1, 2, 3 and 4, the new figure names would be 1a, 1b, 1c, 1d, etc. In addition, each image needs to contain the lettering. Your text and figures legend will need to be updated with the new numbers as well. There is a link in the upper right-hand corner you can click on to see an example. Anytime multiple images are submitted under one figure number, the files should be combined as shown in the example above.
Brief Clinical Studies
If you have a single patient or two patients with spectacular results or use of an innovative procedure or rare syndrome to introduce to the global community and share your knowledge and experience, we will publish this, after positive peer review, as a Brief Clinical Study. These types of submissions should have good educational value, they should be short and to the point, with a good conclusion and have a valuable message to our readership. Submission guidelines are as follows:
Contributing author are limited to 3
Unstructured abstract of no more than 150 words
4 pages of double-spaced text pages (1500 word max), which include your Figures Legend and References
Reference max of 10
Figures are limited to a maximum of 2, however composites may be submitted for each. (Please see Composite guidelines also listed on our Instructions for Authors
ALL Tables should be submitted as supplemental digital content
Submission Check List:
ALL figures and supplemental tables must be cited consecutively in your manuscript.
Number figures in the figure legend in the order in which they are discussed.
Upload figures consecutively to the Editorial Manager web site and enter figure numbers consecutively in the Description field when uploading the files.
Only 1 figure per file.
Do not embed figures or supplemental tables in your text.
Photographs of recognizable persons should be accompanied by a signed release from the patient or legal guardian authorizing publication. Masking eyes to hide identity is not sufficient.
Figure legends: A Figures Legend must be submitted on all papers that contain figures. The descriptions should be brief and specific, and and the complete legend should appear on a separate manuscript page after the references. Use scale markers in the image for electron micrographs and indicate the type of stain used. This is required with each submission and should be the last page of your text. DO NOT embed images on your legend.
Color figures: The editorial board recommends your figures be submitted in color to enhance the educational value of the article and to improve the overall focus. Figures are published in color at the expense of the author. In some cases, the cost will be shared between the author and the journal. The editor will make this determination. Color costs are charged at a rate of $500 for the first figure and $100 for each additional figure. While the authors may decide not to pay for the color reproduction and may request that the figures be converted to black and white, the editor has the right to refuse publication of a figure or figures or even the article if that figure or those figures, in black and white, are felt to detract from the manuscript or serve no purpose in its publication.
Tables: ALL tables must be submitted as Supplemental Digital Content. ALL tables must be cited consecutively in the text and number them in that order. Tables must be created and submitted in WORD using Table Tools. Tables CANNOT be charts, graphs, flowcharts or pictures. As all tables are supplemental content, it is ok to group them in one supplemental table file. Each table must include a table title, appropriate column heads, and explanatory legends (including definitions of any abbreviations used). Do not embed tables within the text of the manuscript. Your paper will be returned to you if the tables are embedded in the text. Tables should be self-explanatory and should supplement, rather than duplicate, the material in the text. Starting January 2019, All ALL TABLES will be Supplemental Digital Content. Please be sure to cite your tables accordingly.
Style: Pattern manuscript style after the American Medical Association Manual of Style (9th edition). Stedman's Medical Dictionary (27th edition) and Merriam Webster's Collegiate Dictionary (10th edition) should be used as standard references. Refer to drugs and therapeutic agents by their accepted generic or chemical names, and do not abbreviate them. Use code numbers only when a generic name is not yet available. In that case, supply the chemical name and a figure giving the chemical structure of the drug. Capitalize the tradenames of drugs and place them in parentheses after the generic names. To comply with trademark law, include the name and location (city and state in USA; city and country outside USA) of the manufacturer of any drug, supply, or equipment mentioned in the manuscript. Use the metric system to express units of measure and degrees Celsius to express temperatures, and use SI units rather than conventional units.
Supplemental Digital Content: Authors may submit supplemental digital content to enhance their article's text and to be considered for online-only posting. Supplemental digital content may include the following types of content: text documents, graphs, tables, figures, graphics, illustrations, audio, and video. Cite all supplemental digital content consecutively in the text. Citations should include the type of material submitted, should be clearly labeled as "Supplemental Digital Content," should include a sequential number, and should provide a brief description of the supplemental content. Provide a legend of supplemental digital content at the end of the text. List each legend in the order in which the material is cited in the text. The legends must be numbered to match the citations from the text. Include a title and a brief summary of the content. For audio and video files, also include the author name, videographer, participants, length (minutes), and size (MB). Authors should mask patients' eyes and remove patients' names from supplemental digital content unless they obtain written consent from the patients and submit written consent with the manuscript. Copyright and Permission forms for article content including supplemental digital content must be completed at the time of submission.
Supplemental Digital Content Size & File Type Requirements: To ensure a quality experience for those viewing supplemental digital content, it is suggested that authors submit supplemental digital files no larger than 100 MB each. Documents, graphs, and tables may be presented in any format. Figures, graphics, and illustrations should be submitted with the following file extensions: .tif, .eps, .ppt, .jpg, .pdf, .gif. Audio files should be submitted with the following file extensions: .mp3, .wma. Video files should be submitted with the following file extensions: .wmv, .mov, .qt, .mpg, .mpeg, .mp4, .wav. Video files should also be formatted with a 320 X 240 pixel minimum screen size. For more information, please review LWW's requirements for submitting supplemental digital content: http://links.lww.com/A142.
After Acceptance
Page proofs and corrections: Corresponding authors will receive page proofs to check the copyedited and typeset article before publication. It is the author's responsibility to ensure that there are no errors in the proofs. Changes that have been made to make the article conform to journal style should be allowed to stand if they do not alter the authors' meaning. Authors may be charged for alterations to the proofs beyond those required to correct errors or to answer queries. Proofs must be checked carefully and returned within 24 to 48 hours of receipt, as requested in the cover letter accompanying the page proofs, otherwise, publication may continue on the assumption that the article is approved without alterations. Authors should note, the editor in chief has the final say on article type of the paper. Therefore, the article type may be changed after acceptance. All papers have the same value. An article type change will not alter the value of your paper.
Please note, all article types carry the same weight and have the same value. The categorization system is at the prerogative of the editor in chief and article types will be adjusted accordingly.
Reprints: Authors will receive a reprint order form and a price list with the page proofs. Reprint requests should be faxed with the corrected proofs, if possible. Reprints are normally shipped 6 to 8 weeks after publication of the issue in which the item appears. Contact the Reprint Department, Lippincott Williams & Wilkins, 351 W. Camden Street, Baltimore, MD 21201; Fax: 410.528.4434; E-mail: reprints@lww.com with any questions.
Publisher's contact: Fax corrected page proofs, reprint order form, and any other related materials to 443-451-8134 (include your article reference number with the changes).
